AQST

Aquestive Therapeutics

• TipRanks·03/31 19:34

  Aquestive Therapeutics Faces Investor Lawsuit Over Alleged Misleading Statements About Anaphylm FDA Approval Timeline 

• TipRanks·03/30 19:30

  Analysts Offer Insights on Healthcare Companies: Aquestive Therapeutics (AQST) and Insmed (INSM)

• TipRanks·03/30 13:10

  Aquestive Advances Anaphylm NDA Resubmission After FDA Meeting

• TipRanks·03/30 12:51

  Analysts Are Bullish on These Healthcare Stocks: Alumis Inc. (ALMS), Aquestive Therapeutics (AQST)

• TipRanks·03/30 11:16

  Aquestive Therapeutics completes Type A meeting with FDA for Anaphylm NDA

• Benzinga·03/30 11:15

  Aquestive Therapeutics Completes In-Person Type A Meeting With FDA Regarding Resubmission Of NDA For Anaphylm Sublingual Film For Treatment Of Type 1 Allergic Reactions, Including Anaphylaxis

• Reuters·03/30 11:05

  Aquestive plans PK, human factors studies ahead of Anaphylm NDA resubmission in Q3 2026

• Reuters·03/30 11:00

  AQUESTIVE THERAPEUTICS INC - CONTINUES TO ADVANCE REGULATORY SUBMISSIONS FOR ANAPHYLM IN CANADA AND THE EUROPEAN UNION

• Reuters·03/30 11:00

  AQUESTIVE THERAPEUTICS INC - RECEIVES CLARIFYING FEEDBACK FROM FDA ON PHARMACOKINETIC (PK) & HUMAN FACTOR (HF) STUDY DESIGNS

• Reuters·03/26 13:03

  Aquestive Therapeutics faces securities lawsuit; shares fell from $6.21 to $3.91 on FDA-cited Anaphylm NDA deficiencies

• TipRanks·03/20 11:57

  Aquestive Therapeutics Announces Key Legal Leadership Transition

• TipRanks·03/20 11:11

  Aquestive chief legal officer, chief compliance officer Lori Braender steps down

• Reuters·03/20 11:03

  Aquestive Therapeutics names Thomas A. Zalewski chief legal and compliance officer

• Reuters·03/20 11:00

  AQUESTIVE THERAPEUTICS ANNOUNCES NEW ROLE OF LORI J. BRAENDER AND APPOINTMENT OF THOMAS A. ZALEWSKI AS CHIEF LEGAL OFFICER AND CHIEF COMPLIANCE OFFICER

• Reuters·03/19 16:01

  Class action lawsuit targets Aquestive Therapeutics over alleged securities law violations